Global health experts warn that US retreat from TB prevention programs could lead to a resurgence of the deadliest infectious ...

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, ...

The ability to monitor this disease, save lives and protect the health of Americans grows weaker by the day as the U.S.

"What are sometimes called superbugs — microbes resistant to every available drug — are not merely the stuff of nightmares.

Learn how new TB treatments show higher success rates and fewer side effects with shorter, all-oral regimens. Discover more.

Practecal, a phase 2b-3 randomised controlled trial which identified a new treatment regimen for drug resistant tuberculosis (TB), cost €33.9m (£28.95n; $38.54m), with an average cost of €61 460 per ...

Study Finds Three New Safe, Effective Ways to Treat Drug-Resistant Tuberculosis Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB.

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

The World Health Organization says nearly 11 million people around the world were diagnosed with tuberculosis in 2023. Author ...

Pakistan ranks fifth globally in the number of tuberculosis (TB) cases and fourth for drug-resistant TB, a concerning ...

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, to less than $1 per day, primarily owing to Indian manufacturers ...